Skip to main content
Clinical Trials/NL-OMON47175
NL-OMON47175
Completed
Not Applicable

Obtaining and analyzing plasmasamples from patients with non small cell lung cancer, referred for radiation treatment and/or chemotherapy - ICD

MAASTRO clinic0 sites20 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
non small cell lung cancer
Sponsor
MAASTRO clinic
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Participant is willing and able to give informed consent for participation in the trial.
  • Male or female, aged 18 years or above.
  • Diagnosed with non\-small cell lung cancer
  • Scheduled to receive one of the following two therapeutic strategies:
  • \- Concurrent cisplatin\-doublet chemotherapy and radiotherapy (minimal dose of 60 Gy in fractionated non\-ablative doses) in patients with stage III NSCLC
  • \- SBRT for stage I NSCLC: 54Gy in 3 fractions, 48 Gy in 4 fractions or 60 Gy in 8 or 5 fractions
  • Is able and willing to comply with all trial requirements.

Exclusion Criteria

  • \- Chronic use of corticosteroids, except when used as anti\-emetics for chemotherapy or inhalers
  • \- NSAIDs taken until 5 days before radiotherapy or during radiation (low dose Aspirin at a maximum of 160 mg/day, is allowed)
  • \- Active auto\-immune diseases
  • \- Immunosuppressive medication

Outcomes

Primary Outcomes

Not specified

Similar Trials